Skip to content

Validation of Brain Function Assessment Algorithm for mTBI/Concussion

Validation of Brain Function Assessment Algorthm for mTBI From Initial Injury to Rehabilitation and Treatment Optimization in Concussion Clinics

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT03671083
Acronym
CAS13-25V
Enrollment
309
Registered
2018-09-14
Start date
2018-10-01
Completion date
2019-03-29
Last updated
2019-05-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Brain Injuries, Traumatic, Concussion, Brain, Concussion, Intermediate, Concussion, Mild, Concussion, Severe

Keywords

Concussion, Sports Related Concussion, Mild Traumatic Brain Injury, Non-Sport Related Concussion

Brief summary

This study is Part 2 of data collection from 13-25 years old subject population for validation of previously derived algorithms. This data will be combined with that collected under NCT02957461 (Part 1 with subject age range 18-25 years) for the final analyses of validation of the algorithms.

Detailed description

EEG, neurocognitive performance and clinical data will be collected at time of injury (within 3 days) at clinically determined Return to Play (RTP) and 45 days after RTP, for the purpose of independently validating the performance of the algorithms developed in prior studies (NCT02477943, NCT02661633 and NCTXXXXXX). Data collected under this study will be combined with that collected under NCT02957461 for the final analyses of prospective algorithm performance in an independent population ages 13-25 years. Subjects will come from the sports and other populations of concussed individuals. They will be matched with controls i.e. not head injured subjects who will also undergo the same set of tests and the same time intervals as the injured subjects. An additional pool of uninjured (not head injured) subjects will be collected who will be assessed at a single time point.

Interventions

The BrainScope Battery evaluation will consist of 4 tests to aid in the assessment of concussion: History, Physical, signs and symptoms (SAC, SCAT5), Electrophysiological Function; Neurocognitive Performance Assessment, Ocular Motor Assessment. BrainScope Ahead 300iP will be used to perform EEG and Cognitive assessments.

Sponsors

BrainScope Company, Inc.
Lead SponsorINDUSTRY

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
13 Years to 25 Years
Healthy volunteers
Yes

Inclusion criteria

For Injured subjects: 1. Having sustained a traumatic closed head injury within 72 hours (3 days) from time of injury at time of BrainScope assessment; 2. GCS 13-15 at time of BrainScope assessment; 3. No hospital admission due to either head injury or collateral injuries for \>24 hours. For Matched Controls: 1. GCS 15 at time of BrainScope assessment; 2. No prior history of concussion or TBI in the last year.

Exclusion criteria

1. Previously enrolled in the BrainScope CAS Studies; 2. Current CNS active prescription medications taken daily, with the exception of medications being taken for the treatment of Attention Deficit Disorder (ADD) or Attention Deficit Hyperactivity Disorder (ADHD); 3. Forehead, scalp or skull abnormalities that prevents headset application or EEG data collection; 4. History of brain surgery or neurological disease; 5. Pregnant women; 6. Subjects who do not speak English (non-English speaking parents are allowed to consent so long as translation of the consent form in their native language is available); 7. Acute intoxication; 8. Evidence of illicit drug usage; For Injured subjects: 1. Loss of consciousness ≥ 20 minutes related to the concussion injury; 2. Active fever defined as greater than 100ºF or 37.78ºC at time of BrainScope assessment; 3. Evidence of abnormality visible on Computerized Tomography (CT) of the head related to the traumatic event (Note: neuroimaging is not required for enrollment). For Matched Controls: 1. Any focal neurological signs including aphasia, apraxia, diplopia, facial droop, dysarthria/slurred speech; 2. History of Motor Vehicle Accident (MVA) requiring an Emergency Department visit within the past 1 year.

Design outcomes

Primary

MeasureTime frameDescription
Likelihood of being concussed6 months for data acquisition, with each patient studied from time of injury to 45 days after RTPSensitivity and specificity forthe identification of the likelihood of concussion/mTBI at the time of injury using a multi-modal EEG-based Concussion Index (CI)

Secondary

MeasureTime frameDescription
Significance of change over time6 months for data acquisition, with each patient studied from time of injury to 45 days after RTPSignificant difference in concussion index between time of injury and return to play (RTP)
Prediction of prolonged recovery6 months for data acquisition, with each patient studied from time of injury to 45 days after RTPAccuracy of prediction of prolonged recovery from injury assessment using a multi-modal EEG-based concussion index

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026